May 14 (Reuters) - Mayne Pharma Group Ltd (MYX) :
- EXPECTS 4QFY19 TO BE STRONGER DRIVEN BY REBOUND IN GENERIC PRODUCTS
- JAN-APRIL REPORTED REVENUE $154.1 MILLION, DOWN 15%
- JAN-APRIL GENERIC PRODUCTS $88.9 MILLION, DOWN 32%
- Forums
- ASX - By Stock
- MYX
- News: MYX Mayne Pharma Expects Q4 To Be Stronger Driven By Rebound In Generic Products
News: MYX Mayne Pharma Expects Q4 To Be Stronger Driven By Rebound In Generic Products
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MYX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$5.09 |
Change
-0.010(0.20%) |
Mkt cap ! $422.8M |
Open | High | Low | Value | Volume |
$5.10 | $5.15 | $4.91 | $534.8K | 105.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 747 | $5.09 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.11 | 29 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 155 | 5.110 |
1 | 127 | 5.100 |
2 | 223 | 5.090 |
2 | 148 | 5.080 |
2 | 416 | 5.070 |
Price($) | Vol. | No. |
---|---|---|
5.120 | 261 | 5 |
5.130 | 702 | 6 |
5.140 | 1763 | 6 |
5.150 | 517 | 3 |
5.160 | 3132 | 3 |
Last trade - 12.27pm 11/11/2024 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, MD & CEO
Charles Armstrong
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online